Evidence map›Paper›PMID 40115045›Full record

ArticleWellcome open research2024

Infrastructure, capabilities, and capacities required for clinical trials design and delivery: A rapid scoping review of recommendations and regulations.

Laura Merson, Karolina Witt, Arishay Hussaini, Ayesha Siddiqui, Eli Harriss, Steve Webb, Patricia Njuguna, Divya K Shah, An-Wen Chan, Robert Terry and 4 more

Abstract read
In one paragraph

Article in Wellcome open research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Laura MersonPandemic Sciences Institute, ISARIC, University of Oxford, Oxford, OX3 7LF, UK.ORCID https://orcid.org/0000-0002-4168-1960
Karolina WittPandemic Sciences Institute, ISARIC, University of Oxford, Oxford, OX3 7LF, UK.
Arishay HussainiCritical Care Medicine, Ziauddin University, Karachi, Sindh, 75000, Pakistan.ORCID https://orcid.org/0000-0002-6359-6070
Ayesha SiddiquiCritical Care Medicine, Ziauddin University, Karachi, Sindh, 75000, Pakistan.ORCID https://orcid.org/0000-0003-1555-720X
Eli HarrissBodleian Health Care Libraries, University of Oxford, Oxford, England, OX1 3BG, UK.
Steve WebbAustralian and New Zealand Intensive Care Research Centre, Monash University, Clayton, Victoria, 3004, Australia.ORCID https://orcid.org/0000-0001-9134-9045
Patricia NjugunaProgram for Appropriate Technology in Health (PATH), Nairobi, Kenya.
Divya K ShahInfectious Disease, Wellcome Trust, London, England, NW1 2BE, UK.
An-Wen ChanUniversity of Toronto, Toronto, Ontario, M5T 3M6, Canada.
Robert TerrySpecial Programme for Research and Training in Tropical Diseases (TDR), Geneva, 1211, Switzerland.ORCID https://orcid.org/0000-0003-3849-7705
Nandi SiegfriedSouth African Medical Research Council, Cape Town, 19070, South Africa.
Jeni StolowPublic Health and Tropical Medicine, Tulane University, New Orleans, Louisiana, 70112, USA.ORCID https://orcid.org/0000-0001-8926-1861
Emmanuelle DenisPandemic Sciences Institute, ISARIC, University of Oxford, Oxford, OX3 7LF, UK.ORCID https://orcid.org/0000-0001-8463-1341
Madiha HashmiCritical Care Medicine, Ziauddin University, Karachi, Sindh, 75000, Pakistan.ORCID https://orcid.org/0000-0002-7332-0692

Funding

Wellcome Trust
6 · The paper itself

Abstract

Objective: Synthesise the published literature and national regulations on infrastructure, capabilities and capacities required to manage and quality assure clinical research. Introduction: The World Health Assembly (WHA) resolution 75.8 (2022) called "for a strengthened global architecture for coordinated and high-quality clinical trials". For this remit, infrastructure, capabilities, and capacities needed to design and deliver high-quality clinical trials must be understood and advanced. This rapid scoping review aims to identify the breadth of requirements and recommendations for effective management of clinical trials in regulations, national legislation and the published literature. The findings will be summarised into themes. It will inform a framework for the assessment and development of units undertaking observational studies and interventional clinical trials. Inclusion criteria: Peer-reviewed literature, grey literature, and national legislation that recommends infrastructure, capabilities, and/or capacities needed to manage and quality assure clinical trials. Publications authored by those who design, manage, fund, sponsor, regulate or oversee clinical trials. Methods: Peer-reviewed and grey literature will be identified through Medline, Embase, PsycINFO, and Global Health via Ovid; SCOPUS; the Web of Science Core Collection; and the WHO Global Index Medicus using specific field codes to increase the specificity of the search strings. No date, language, or geographic limits will be applied. Deduplicated titles and abstracts will be screened by two blinded reviewers with discrepancies resolved by a third reviewer. Grey literature may be identified through the peer reviewed literature, supplemented with structured searches of Google and DynaMed. National regulations will be sourced online and from available summaries. Full text literature and regulations will be screened by a single reviewer, with proportionate verification by a second reviewer. Data will be extracted and coded for patterns in NVivo software. All items and codes will be summarised using a thematic framework analysis and identify core constructs within each theme.

Indexed as

quality assuranceQuality by designquality controlresearch managementresearch qualityresearch standards

Identifiers

PMID40115045
PMCPMC11923532

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.